Henry Schein, Inc. (HSIC) Stake Maintained by Regent Investment Management LLC
Regent Investment Management LLC held its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, Holdings Channel reports. The institutional investor owned 3,500 shares of the company’s stock at the end of the second quarter. Regent Investment Management LLC’s holdings in Henry Schein were worth $641,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Oregon Public Employees Retirement Fund raised its position in shares of Henry Schein by 3.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 18,958 shares of the company’s stock valued at $3,470,000 after buying an additional 600 shares during the last quarter. AMI Asset Management Corp acquired a new stake in shares of Henry Schein during the second quarter valued at about $25,345,000. Mn Services Vermogensbeheer B.V. increased its stake in shares of Henry Schein by 498.8% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 12,857 shares of the company’s stock valued at $2,353,000 after buying an additional 10,710 shares during the period. Delta Capital Management LLC acquired a new stake in shares of Henry Schein during the second quarter valued at about $209,000. Finally, Baldwin Brothers Inc. MA acquired a new stake in shares of Henry Schein during the second quarter valued at about $1,324,000. Institutional investors own 90.74% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 184.38 on Wednesday. Henry Schein, Inc. has a 52-week low of $146.23 and a 52-week high of $186.99. The stock has a 50 day moving average of $183.71 and a 200 day moving average of $172.63. The firm has a market cap of $14.63 billion, a price-to-earnings ratio of 28.02 and a beta of 1.09.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 9th. The company reported $1.76 EPS for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.11. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The company had revenue of $2.92 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter last year, the firm posted $1.41 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post $7.28 EPS for the current fiscal year.
Several analysts have issued reports on HSIC shares. Craig Hallum started coverage on shares of Henry Schein in a report on Tuesday, April 11th. They issued a “hold” rating on the stock. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a report on Tuesday, April 25th. Stifel Nicolaus upped their price target on shares of Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a report on Wednesday, May 10th. Barrington Research upped their price target on shares of Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Finally, Piper Jaffray Companies started coverage on shares of Henry Schein in a report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price target on the stock. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $182.60.
In other news, EVP Gerald A. Benjamin sold 12,578 shares of Henry Schein stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total value of $2,202,407.80. Following the transaction, the executive vice president now owns 44,061 shares of the company’s stock, valued at $7,715,081.10. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.